Head Position Monitoring After Pars Planar Vitrectomy
HPMPPV
Compliance of Head Positioning After Pars Planar Vitrectomy With Tamponade
1 other identifier
observational
100
1 country
1
Brief Summary
In ophthalmic surgical practice, particularly for treating retinal detachment and macular hole disorders, vitrectomy procedures are routinely performed to remove the vitreous body followed by the injection of tamponade agents such as gaseous compounds (e.g., C3F8 or SF6) or silicone oil. These tamponade materials function by creating internal pressure against the retinal surface to facilitate reattachment. A critical determinant of surgical success in these cases is postoperative head positioning (prone posturing), as improper alignment may compromise the tamponade effect. At the investigators' institution, participants undergoing such procedures are prescribed a strict prone position regimen for 7 consecutive postoperative days. This facedown positioning protocol aims to optimize interfacial contact between the tamponade agent and retinal tissue. However, conventional clinical practice faces a significant limitation: the inability to objectively verify patient compliance with prescribed postural guidelines outside clinical settings. Subjective patient reporting and intermittent clinical observations prove insufficient for quantifying adherence levels. To address this critical gap in postoperative monitoring, the investigators propose implementing a novel electronic monitoring system integrated into therapeutic eye patches. This advanced device incorporates a miniaturized triaxial gyroscopic sensor array capable of continuously tracking cephalo-cervical orientation with high angular resolution. The system features complete electrical isolation from ocular tissues while maintaining sterility. Data acquisition occurs through a microSD card (capacity: 16GB) that logs positional parameters at 0.2Hz sampling frequency, creating comprehensive temporal records of head movement patterns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2024
CompletedFirst Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2025
CompletedMay 22, 2025
March 1, 2025
6 months
March 24, 2025
May 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Compliance of head positioning
1. % time of right head positioning time (%) 2. % time of applying eye patch time (%) 3. Averaged deviation from instructed positioning (degree) 4. % time of cotact between tamponade and retinal tear or macular hole (%) 5. Questionaire (Visual Analogue Scale) : * pain, disability in daily life (dressing, eating, sleeping, washing, households)
From enrollment to 7 days after surgery
Secondary Outcomes (1)
Baseline demographic and ocular characteristics
At enrollment
Interventions
Small pcb with gyroscope and lithium polymer battery embedded eyeshield will be distributed right after surgery
Eligibility Criteria
patients who get vitrectomy with gas or silicone oil tamponade followed by positioning prescription
You may qualify if:
- Patients who get vitrectomy
You may not qualify if:
- Patients who cannot maintain positioning due to their physical disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital, dep. of Ophthalmology
Seoul, 03080, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2025
First Posted
May 22, 2025
Study Start
November 28, 2024
Primary Completion
May 31, 2025
Study Completion
June 7, 2025
Last Updated
May 22, 2025
Record last verified: 2025-03